1<!DOCTYPE html> 2<html lang="en-US"><meta charset="utf-8"/> 3<head> <meta name="viewport" content="width=device-width, initial-scale=1"> 4 <meta name="author" content="imran"/> 5<title>If you need any type of help contact us</title> 6 <meta name="keywords" content="help, for, cidp, cidpusa, pakistan, karachi, usa, lahore, India disease, faq,questions, treatment, hospital, clinic"> 7<meta name="description" content="Help for autoimmune diseases from cidpusa, re IVIG, in any country of the world"> 8<link rel="canonical" href="http://cidpusa.org/help.htm" /> 9<style> 10* { 11 box-sizing: border-box; 12} 13.menu { 14 float: left; 15 width: 20%; 16} 17.menuitem { 18 padding: 8px; 19 margin-top: 7px; 20 border-bottom: 1px solid #ffffOO; 21} 22.main { 23 float: left; 24 width: 60%; 25 padding: 0 20px; 26 overflow: hidden; 27} 28.right { 29 background-color: lightblue; 30 float: left; 31 width: 20%; 32 padding: 10px 15px; 33 margin-top: 7px; 34} 35 36@media only screen and (max-width:800px) { 37 /* For tablets: */ 38 .main { 39 width: 80%; 40 padding: 0; 41 } 42 .right { 43 width: 100%; 44 } 45} 46@media only screen and (max-width:500px) { 47 /* For mobile phones: */ 48 .menu, .main, .right { 49 width: 100%; 50 } 51} 52elem.addEventListener('touchstart', fn, 53 detectIt.passiveEvents ? {passive:true} : false); 54 55</style> 56 57</head> 58<body style="font-family:Verdana;"> 59 60<div style="background-color:#f1f1f1;padding:15px;"> 61 <h1>CIDPUSA.ORG</h1> 62 <h3>Autoimmune DIseases</h3> 63</div> 64 65<div style="background-color:#fff000"> 66 <div class="menu"> 67 <div class="menuitem"> <a href="index.html">Home</a></div> 68 <div class="menuitem"><a href="FAQ.htm">FAQ</a></div> 69 <div class="menuitem"><a href="services.html">services</a></div> 70 <div class="menuitem">Links below</div> 71 </div> 72 73 <div class="main"> 74 <h1>Help CidpUsa</h1> 75<p> <strong>Hello!</strong> 76<span class="auto-style2">We provide help with guidance on a daily basis to guide you with your disease we have had many patients who werdiagnosed with ALS who are today doing well 77because we sent them to the right doctors got the right medicine see the story from our home page, send us a enquiry or ask a question. 78People on ships or remote islands will get accurate help and guidance for alternative treatments Please contact us for support. We will help in connecting patients to physicians . 79Help in insurance issues and providing research and medical literature to guide you and your doctor to current treatments. Please see the 80<a href="services.html">service link for contact & services</a>. We have satisfied patients in many countries and remote location all help provided remotely by internet or telephone. Most help is by natural and alternative treatments we treat the cause of the disease not the symptoms as is 81done in conventional medicine.<br>If you need research articles to be sent to your doctor we can do that for you at cost.<br>A woman in a remote island of Africa with CIDP was shipped a electronic device and 4 years later she is alive 82and well.<br>A young man who had been to three neurologist who examined him and said that there was nothing wrong with him. We referred him to new neurologist and sent the guidelines by Dr Dalakas . This resulted in a IVIg prescription 83and of course followed by improvement in this 84young mans condition.</span></p> 85 <p> 86 87</p> 88 <p> <p><!--webbot bot="HTMLMarkup" startspan -->
88<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
88<!-- Shazi --><ins class="adsbygoogle" style="display:block" data-ad-client="ca-pub-2916272636299030" data-ad-slot="3007269386"data-ad-format="auto" data-full-width-responsive="true"></ins>
88<script> (adsbygoogle = window.adsbygoogle || []).push({});</script>
88<!--webbot bot="HTMLMarkup" endspan --></p> 89 90</p><p>Our first treatment for CIDP is homeopathic 91works in 95% of the people we treat. The second 92line treatment are antibiotics and both these 93treatments reverse the cause of the disease. 94Intravenous immune globulin (IVIG) has also been 95found to be beneficial. It remains the 96cornerstone of CIDP treatment for allopathic 97conventional medicine. IVIG is usually given in 98divided doses over 4 or 5 consecutive days at a 99total dose of 2g/kg. Dr. Dalakas has shown that 100if the total infusion can be given in two large 101doses it works better for the patient. He also 102recommends that for all the neurological 103disorders the dose of IVIg should be 2gm/kg. The 104cost of such a treatment at $80 a gram is over 105$10,000 a infusion. Would you like to try a 106homeopathic which will probably cure your 107disease and cost $40.<br>For remote locations we 108provide alternatives every corner of the world.<br> 109 Maintenance doses of IVIg are often needed at 110monthly intervals to maintain clinical response. 111Serious side effects of IVIG treatment are rare, 112(fatal anaphylaxis in IgA-deficient patients 113seen in { In patients who have anti IgA 114antibodies}. We recommend that before the 115infusion the total IgA level be measured. If the 116level is below 58 then anti IgA ANTIBODIES NEED 117TO BE MEASURED. However a case has been reported 118with IgA LEVEL of 58 who later developed IgA 119reaction. So a careful history should be taken 120of all patients first starting IVIg.<br> Also if 121the lab reports IgA <20 IT MAY BE SAFE TO ASSUME 122THAT IT IS ZERO.<br </p> 123 124 <p><!--webbot bot="HTMLMarkup" startspan -->
124<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
124<!-- Shazi --><ins class="adsbygoogle" style="display:block" data-ad-client="ca-pub-2916272636299030" data-ad-slot="3007269386"data-ad-format="auto" data-full-width-responsive="true"></ins>
124<script> (adsbygoogle = window.adsbygoogle || []).push({});</script>
124<!--webbot bot="HTMLMarkup" endspan --></p> 125<span class="auto-style2">> Potential nephrotoxicity, 126especially in patients with pre-existing renal 127disease. <br>For those that are resistant to 128IVIg therapy one needs to check if the dose 129being given is correct. If the dose has been 1302g/kg then one can consider adding steroids to 131the IVIg. If that does not work then 132Cyclophosphamide, Rituxan, Cyclosporin can be 133considered.<br>IVIg is used as a rescue therapy 134or first line agent and then a second line agent 135is started like cyclosporin. In time this 136becomes the agent of choice for chronic 137maintenance. <br>Do not forget about supplements 138we recommend alpha lapoic acid and colostrum 139with omega 3 fatty acids.<br>.</p> 140 <p> 141We provide a guide to help you improve through 142natural alternative means.</span></p> 143 <a href="FAQ_diseases.htm" class="auto-style1">Please proceed to page-2 of Help and FAQ 144 about Autoimmune Diseases</a></p> 145 146 </div> 147 148 <div class="right"> 149 <h2>links</h2> 150 <a href="ALS.html">Study showing ALS </a></p><p> 151<a href="GBS%20STORY.htm">A girl battles back from GBS</a></p><p> 152<a href="stiff%20girl.html">A girl with stiff person syndrome</a></p><p> 153<a href="SOLUTHAFRICAN.html">Young girl with CIDP</a></p><p> 154<a href="dermatatomyositis.htm"> Dermatomyositis</a></p><p> 155<a href="Lymes.htm" >Lymes disease case approved for IVIG by Health Net</a> ( a story that touches the heart)</p><p> 156<a href="lyme.htm" >Lymes causes autoimmune disease</a></p><p> 157<a href="athlete.htm" >Athlete gets nerve disease</a></p><p> 158<a href="truck%20driver.html" >Truck driver gets Stiff person syndrome</a></p><p> 159<a href="MS.htm" >MS does not stop star athlete</a></p><p> 160<a href="alexandria%20story.htm" >Another good CIDP story</a></p><p> 161<a href="johnson.html" >A GBS story</a></p><p> 162<a href="FAQ_diseases.htm" class="button next">Next Page</a>
163<script type="text/javascript" id="clustrmaps" src="//cdn.clustrmaps.com/map_v2.js?d=kj1cK817QQl0gwzfXuOKGisVM11WUBIKMGr-w31ctOc"></script>
163 164 </div> 165</div> 166 167 168<div style="background-color:#FFFOOO;text-align:center;padding:10px;margin-top:7px;font-size:12px;"> This web page is 169 fluid cidpusa page</div> 170 171</body> 172</html>
Line numbers count LF bytes from the start of the resource, as the search results do. Vendor segments are library code the classifier recognised; they are stored but not indexed. Bytes are shown as Latin1 characters, one per byte.